Tarsus Pharmaceuticals CFO Jeffrey Farrow receives $4M in 2023
Tarsus Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: April 26, 2024
Tarsus Pharmaceuticals reported fiscal year 2023 executive compensation information on April 26, 2024.
In 2023, four executives at Tarsus Pharmaceuticals received on average a compensation package of $2.7M, a 14% decrease compared to previous year.
Average pay of disclosed executives at Tarsus Pharmaceuticals
Jeffrey Farrow, Chief Financial Officer, received $4M in total. 42% of Farrow's compensation, or $1.7M, was in stock awards. Farrow also received $100K in bonus, $241K in non-equity incentive plan, $1.6M in option awards, $344K in salary, as well as $38K in other compensation.
Bobak Azamian, Chief Executive Officer, received a compensation package of $3.1M, which decreased by 20% compared to previous year. 33% of the compensation package, or $1M, was in stock awards.
Leonard Greenstein, Chief Financial Officer, earned $2M in 2023.
Seshadri Neervannan, Chief Operating Officer, received $1.7M in 2023.
Related executives
You may also like
Source: SEC filing on April 26, 2024.